Stereotactic Radiotherapy for Brain Metastases
NCT03286023 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2022-06-22
Summary
Stereotactic radiotherapy is an innovative treatment enabling to target accurately brain metastases. The aim of this study is to evaluate tumoral response and acute and late toxicity of this treatment.
Conditions
- Metastasis Brain
Interventions
- RADIATION
-
stereotactic radiotherapy
stereotactic radiotherapy for brain metastases
Sponsors & Collaborators
-
Centre Francois Baclesse, Luxembourg
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2019-10-31
- Completion
- 2022-12-31
Countries
- Luxembourg
Study Locations
More Related Trials
-
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
NCT02390518 ·Status: RECRUITING ·Phase: PHASE1
-
FSRT in Breast Cancer Patients With Brain Metastases
NCT04061408 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases
NCT07135817 ·Status: RECRUITING ·Phase: NA
-
Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases
NCT02798029 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases
NCT03368625 ·Status: COMPLETED ·Phase: NA
-
Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis
NCT01169116 ·Status: WITHDRAWN ·Phase: PHASE2
-
Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases
NCT01169129 ·Status: WITHDRAWN ·Phase: PHASE3
-
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
NCT07132190 ·Status: RECRUITING ·Phase: PHASE2
-
a Feasibility Study of iHD-SRT for BM
NCT06231186 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
NCT03391362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
NCT04299646 ·Status: RECRUITING ·Phase: PHASE2
-
FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma
NCT07058428 ·Status: RECRUITING ·Phase: PHASE3
-
Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain Metastases
NCT04787185 ·Status: UNKNOWN
-
Short Course Radiation Therapy in Palliative Treatment of Brain Metastases
NCT03525301 ·Status: UNKNOWN ·Phase: NA
-
Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer
NCT00536861 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radiotherapy for Liver Tumors
NCT01347333 ·Status: COMPLETED ·Phase: NA
-
Dosimetric Validation of Scans Generated by GAN From Pre-therapeutic MRI in Stereotactic Cerebral Radiotherapy
NCT04525053 ·Status: COMPLETED
-
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
NCT03392233 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I Study of Fractionated Stereotactic Radiation Therapy
NCT03726359 ·Status: RECRUITING ·Phase: PHASE1
-
WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
NCT06243003 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors
NCT04242342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SBRT in the Management of Solid Spinal Metastases
NCT04863612 ·Status: RECRUITING
-
Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases
NCT02220491 ·Status: COMPLETED ·Phase: NA
-
Pre- Versus Post-operative SRS for Resectable Brain Metastases
NCT04474925 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT
NCT04452084 ·Status: COMPLETED ·Phase: PHASE2